Drugs/Therapy
Drugs/Therapy
Latest News
-
5 Tips To Stay Clean And Sober
By Ivan Seranno | May 24, 2019 11:54 AM EDTHere are 5 tips to stay clean and sober, and why it’s important to understand that your past addictions don’t have to define your future.
-
Is CBD a Preventative Treatment?
By Staff Reporter | May 05, 2019 10:40 PM EDTIn this guide we'll explore the potential of CBD as a preventative treatment.
-
NEJM applying universal standards of care to Ebola virus disease
By Staff Reporter | Apr 13, 2019 11:04 AM EDTDr Shevin Jacob is corresponding author on a perspective piece published in the New England Journal of Medicine calling for universal standards of care to be applied in relation to Ebola Virus Disease
-
Lack of access to antibiotics is a major global health challenge
By Staff Reporter | Apr 13, 2019 11:05 AM EDTAntibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While "overuse" of antibiotics is widely accepted as a major health challenge
-
Blocking opioid receptors could reduce hormone-therapy-fueled increases in sugar intake
By Staff Reporter | Apr 22, 2019 11:36 PM EDTEstradiol is a commonly prescribed estrogen therapy. Previous research has found that rats treated with the hormone experience an increase in sugar consumption
-
Tidying up: A new way to direct trash to autophagy
By Staff Reporter | Apr 22, 2019 11:36 PM EDTMarie Kondo herself couldn't do it any better. Usually cells are good at recognizing what doesn't spark joy. They're constantly cleaning house -- picking through their own stuff to clear out what no longer works.
-
Does Marijuana Legalization Lead To More Car Accidents?
By Staff Reporter | Apr 01, 2019 10:14 PM EDTHere’s everything we know about legal weed and the way it’s changing our roadways.
-
How An Apology Can Go A Long Way After A Medical Error
By Staff Reporter | Apr 01, 2019 10:17 PM EDTHere’s how an apology can go a long way after a medical error.
-
Deep brain stimulation provides sustained relief for severe depression
By Staff Reporter | Mar 20, 2019 08:23 AM EDTWorld's largest study of deep brain stimulation in the brain's reward system Study with 16 participants with previously treatment-resistant depression shows excellent results over one year Results published in the journal Neuropsychopharmacology Patients suffering from severe, treatment-resistant depression can benefit not only acutely but also the long-term from deep brain stimulation, as researchers from the Medical Center - University of Freiburg and their colleagues from the University Hospital Bonn demonstrate in a current study. The team used thin electrodes to stimulate a deep seated part of the reward system in the brains of 16 patients. This led to a significant reduction of ratings of depression severity in all patients, it was reduced by half on average. For half of the study participants it was even reduced below the level regarded as the threshold for a depression requiring treatment. Most of the patients experienced those positive stimulation effects within the first week, and they lasted throughout the course of the one-year study. The study was published online in the Nature journal Neuropsychopharmacology on Thursday, 14 March 2019. "The most compelling outcome from the study is the sustained efficacy in very severely ill patients. Most treatments in psychiatry cease to be efficacious after moths and years, we demonstrated for the first time in demonstrating in a relatively large-scale study that deep brain stimulation is a real option for those patients suffering from treatment-resistant, severe depression," says group leader Prof. Dr. Thomas Schläpfer, head of the Division of Interventional Biological Psychiatry at the Medical Center - University of Freiburg. Success after Dozens of Unsuccessful Treatments An estimated 10 to 30 percent of all people with recurring depression do not respond to approved treatments. Deep brain stimulation could be a treatment option for some of these patients. The 16 participants in the FORSEE-II study had suffered from severe depression for 8 to 22 years and had previously undergone an average of 18 drug therapies, 20 electroconvulsive therapies, and 70 hours of psychotherapy - without success. Prof. Dr. Volker A. Coenen, first author of the study and director of the Stereotactic and Functional Neurosurgery Unit at the Department of Neurosurgery of the Medical Center - University of Freiburg, and his team implanted the deep brain stimulation systems in the patients medial forebrain bundle of the brain and used them to stimulate the medial forebrain bundle. This brain region is involved in the perception and regulation of pleasure and reward and is thus also significant for motivation and the perceived quality of life. Clear Relief Often within Days The doctors evaluated the success of the therapy monthly with the help of the established Montgomery-Asberg Depression Rating Scale (MADRS). The MADRS scores of ten study participants already decreased significantly within the first week and remained at a low level. All study participants reacted to the stimulation in the course of the study. Eight of the 16 patients had a MADRS score of under 10 points at the end of the study and thus were regarded as non-depressive. "Our patients had struggled with severe depression for years with no signs of improvement. Deep brain stimulation brought most of them significant relief within days, which lasted throughout the course of the therapy. Other forms of treatment like medication and psychotherapy often lose their effectiveness over the course of time. Absolutely sensational about the study data is that the effect seems to be long lasting, with the positive effects continuing for years", says Prof. Schläpfer. "We know from a pilot study that the stimulation of this brain region is very promising and we are delighted about the replication of these significant effects," says Prof. Coenen. Hopes for European Approval of the Method On the basis of the results of the just-published study, the Freiburg researchers already began work on their third study (FORESEE-III) in October 2018. It will involve the treatment of 50 severely depressed patients. Fifteen patients have already been operated. "If the follow-up study is as successful as the current one, we have high hopes for receiving European approval of the method," says Prof. Schläpfer.
-
It's no Fortnite, but it's helping stroke survivors move again
By Staff Reporter | Mar 20, 2019 08:19 AM EDT'Gamified' new rehab therapy helps severely impaired stroke survivors regain arm mobility
-
Hormone therapy may increase cardiovascular risk during gender transition
By Staff Reporter | Feb 25, 2019 11:08 AM ESTPatients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular events, including strokes, heart attacks and blood clots, according to a study published in the American Heart Association's journal Circulation.
-
Antibody therapy training phagocytes to destroy tumors now tested on patients
By Staff Reporter | Feb 25, 2019 11:03 AM ESTDeveloped by researchers at the University of Turku in Finland, an immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer.
-
Promising new therapies for food allergies: A research update
By Staff Reporter | Feb 25, 2019 10:49 AM ESTPromising new therapies for food allergies are on the horizon, including experimental immunotherapy awaiting federal approval that enables people who are very allergic to eat peanut protein without suffering serious side effects.
-
Novel gene therapy approach creates new route to tackle rare, inherited diseases
By Staff Reporter | Feb 20, 2019 09:23 AM ESTNonsense mutations are single-letter errors in the genetic code that prematurely halt the production of critical proteins.
-
Advancing therapy by measuring the 'games' cancer cells play
By Staff Reporter | Feb 19, 2019 08:55 AM ESTDespite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment.
